INSMED INC (INSM)

Director Lewis William 🟡 adjusted position in 10.7K shares (2 derivative) of INSMED Inc (INSM) at $139.60 ($2.0M) Transaction Date: May 04, 2026 | Filing ID: 000026

Register to leave comments

  • News bot May 6, 2026, 8:12 p.m.

    🔍 Lewis William (Director)

    Company: INSMED Inc (INSM)

    Report Date: 2026-05-04

    Transaction Summary:

    • Total transactions: 11
    • Derivative instruments: 2
    • Holdings reported: 1
    • Total shares acquired: 10,699
    • Total shares sold: 21,398
    • Total shares held: 233,924

    Detailed Transactions and Holdings:

    • Acquired 6,259 shares of Common Stock at $30.46 per share (Direct)
      Date: 2026-05-04 | Code: M | equity_swap_involved: 0 | shares_owned_after: 307,444.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 4,440 shares of Common Stock at $17.16 per share (Direct)
      Date: 2026-05-04 | Code: M | equity_swap_involved: 0 | shares_owned_after: 311,884.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 433 shares of Common Stock at $134.18 per share (Direct)
      Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 311,451.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 599 shares of Common Stock at $135.18 per share (Direct)
      Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 310,852.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 5,318 shares of Common Stock at $137.01 per share (Direct)
      Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 305,534.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 2,721 shares of Common Stock at $137.86 per share (Direct)
      Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 302,813.00 | transaction_form_type: 4 | Footnotes: F1, F5
    • Sold 1,247 shares of Common Stock at $139.09 per share (Direct)
      Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 301,566.00 | transaction_form_type: 4 | Footnotes: F1, F6
    • Sold 381 shares of Common Stock at $139.6 per share (Direct)
      Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 301,185.00 | transaction_form_type: 4 | Footnotes: F1
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-05-04 | Code: H | nature_of_ownership: By trust | shares_owned_after: 233,924.00
    • Sold 6,259 shares of Stock Option (right to buy) at $30.46 per share (Derivative)
      Date: 2026-05-04 | Code: M | Expires: 2028-01-04 | equity_swap_involved: 0 | shares_owned_after: 31,296.00 | transaction_form_type: 4 | Footnotes: F1, F7
    • Sold 4,440 shares of Stock Option (right to buy) at $17.16 per share (Derivative)
      Date: 2026-05-04 | Code: M | Expires: 2027-05-17 | equity_swap_involved: 0 | shares_owned_after: 22,200.00 | transaction_form_type: 4 | Footnotes: F1, F7

    Footnotes:

    • F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
    • F2: This is the weighted average sales price representing 433 shares sold at prices ranging from $133.88 to $134.69 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
    • F3: This is the weighted average sales price representing 599 shares sold at prices ranging from $135.06 to $135.50 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
    • F4: This is the weighted average sales price representing 5,318 shares sold at prices ranging from $136.32 to $137.30 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
    • F5: This is the weighted average sales price representing 2,721 shares sold at prices ranging from $137.32 to $138.28 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
    • F6: This is the weighted average sales price representing 1,247 shares sold at prices ranging from $138.52 to $139.43 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
    • F7: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.